IP Verse

Factor Ii And Fibrinogen For Treatment Of Haemostatic Disorders - EP2624859

PATENT ANALYSIS

Patent Details

Grant Date
Mar 1, 2017
Company
MEDIMMUNE LIMITED
Oppositions

STRAWMAN LIMITED

More patents of Medimmune Limited

EP3218406

EP3157629

EP1942939

Want to monitor this patent?

Feel free to send us a message here and we will get back to you